He & She MD Review: The Monthly Price Is Only Part of the Cost

He & She MD’s advertised $99 monthly semaglutide price is not a stand-alone monthly payment option. Its plans page pairs that figure with $1,188 collected annually, while the injectable product page conditions the starting price on purchasing 12 months of supply. That distinction is the starting point for understanding this telehealth service: the monthly equivalent, the amount charged today and the renewal charge are separate numbers. The consulted pages do not consistently align all three.

This documentary review examines He & She MD’s weight-management offering through its payment structure, rather than treating its lowest headline price as the complete cost. Sources consulted October 19, 2026 describe compounded semaglutide and tirzepatide, injectable and oral options, clinical assessment and ongoing support. They also contain materially different nonannual prices, an expired-offer notice and older membership terms. The practical task is to establish exactly which product, payment schedule and service obligations would appear in an individual purchase agreement.

At a glance

Lowest advertised semaglutide price: The plans page advertises compounded semaglutide at $99 per month with $1,188 paid annually; the injectable page ties its starting price to purchasing 12 months of supply.
Sources: [6] [13]
Nonannual prices conflict: Monthly compounded semaglutide is $199 on the plans page versus $249 on its injectable page; tirzepatide is $299 versus $339.
Sources: [6] [13] [11]
Renewal notices matter: Homepage notes describe six-month introductory equivalents of $139 and $199 per month, followed by six-month renewal charges of $1,194 and $1,734, respectively.
Sources: [9]
Advertised inclusions: Plans list prescribed medication, injection supplies, free shipping, ongoing provider support and unlimited messaging, with no membership fees.
Sources: [6]
Self-pay structure: He & She MD does not accept insurance, provide superbills or communicate with insurers. Independently submitted receipts do not guarantee reimbursement.
Sources: [6]

Start with the amount collected, not the monthly equivalent

The plans page provides several ways to pay for compounded semaglutide: $199 billed monthly; $447 every three months, described as $149 per month; $834 every six months, described as $139 per month; or $1,188 annually, described as $99 per month. These are alternative billing arrangements, not a requirement that every patient prepay annually. The page labels savings of $270 for the three-month option and $360 for the six-month option; those are the provider’s promotional comparisons.

For compounded tirzepatide, the same page lists $299 billed monthly, $627 every three months at a $209 monthly equivalent, $1,194 every six months at a $199 monthly equivalent, and $1,908 annually at a $159 monthly equivalent. Its advertised savings are $270 for three months and $540 for six months. The table below preserves the stated collection intervals. It does not establish how much medication is dispensed in each shipment.

An annual purchase creates a different immediate budget requirement from a monthly purchase, even when the monthly equivalent looks lower. The injectable semaglutide page explicitly says its starting $99 price requires purchasing 12 months of supply. That does not establish whether all medication arrives together or in installments. Our explanation of the first payment versus the advertised monthly price provides a useful framework for reading the eventual quote.

Compounded medication prices on the plans page; product-page discrepancies are discussed below.
Billing option	Semaglutide	Tirzepatide
Monthly	$199, billed monthly	$299, billed monthly
Three months	$149/month equivalent; $447 every three months	$209/month equivalent; $627 every three months
Six months	$139/month equivalent; $834 every six months	$199/month equivalent; $1,194 every six months
Annual	$99/month equivalent; $1,188 annually	$159/month equivalent; $1,908 annually

Sources: [6] [13]

The competing price tables cannot be reconciled from the pages alone

The injectable semaglutide page lists $249 for a one-month plan, $219 per month for three months and $199 per month for six months. Those figures exceed the corresponding plans-page prices. Its 12-month figure remains $99 per month. The injectable tirzepatide page similarly lists $339 for one month, $309 per month for three months and $289 per month for six months, while retaining the $159 monthly equivalent for 12 months. The sources do not establish which nonannual schedule governs checkout.

Renewal language adds another layer. One homepage note describes $139 per month for the first six months, then a $1,194 six-month renewal, equivalent to $199 per month. Another describes $199 per month initially, then a $1,734 six-month renewal, equivalent to $289 per month. These resemble the semaglutide and tirzepatide price patterns, respectively, but the supplied material does not conclusively connect every note to every plan card. Nor does the plans page’s recurring-payment wording resolve that introductory distinction.

The homepage also displays a $99 monthly offer based on an annual subscription alongside the statement that the offer has ended. That makes its present availability uncertain, not automatically invalid across every page. Before payment, request the selected product’s initial charge, covered period, next charge date and renewal amount in one written confirmation. A general guide to introductory offers and renewal prices can help separate these terms without assuming the first price continues.

Sources: [13] [11] [9]

Oral tablets have separate prices—and labeling problems

He & She MD markets semaglutide and tirzepatide as both subcutaneous injections and oral tablets. Those presentations should not be collapsed into one price comparison. On the oral semaglutide page, the listed monthly figures are $279 for one month, $259 for three months, $239 for six months and $209 for 12 months. However, the table is headed “Semaglutide Injectable Pricing,” despite appearing on the oral product page. That internal mismatch requires clarification before treating the figures as a reliable tablet quote.

The oral tirzepatide page lists $339 per month for one month, $309 for three months, $289 for six months and $269 for 12 months. Its table is incongruously labeled “Sermorelin Injectable Pricing.” These are documented advertisements, not independently confirmed transaction prices. Neither oral table establishes the collection schedule as clearly as the main plans page does. The supplied sources also leave the tablets’ precise formulations, added ingredients, manufacturer and product-specific regulatory status unresolved.

The broader offering mentions compounded semaglutide and tirzepatide alongside Wegovy, Ozempic, Zepbound and Mounjaro when clinically appropriate and available. The quoted compounded-plan prices do not establish prices for those branded products. FDA approval belongs to a specific product, not to every formulation sharing an ingredient name or to the platform itself. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug; compounded preparations do not undergo FDA premarket review, but nonapproval alone does not establish clinical inequivalence.

Sources: [6] [13] [11] [7] [12] [10] [1]

What the advertised payment includes

The plans page says every plan includes medication if prescribed, injection supplies, free shipping, ongoing provider support and unlimited messaging, without membership fees. The injectable semaglutide page also advertises the same price at every dose, no insurance requirement, 24/7 support and HSA/FSA acceptance. These are provider statements, not independently verified service guarantees. In particular, HSA/FSA acceptance does not settle an individual account’s reimbursement rules, and the same-price statement does not reconcile the competing plan tables.

There are meaningful gaps around the edges of the bundle. The supplied documentation does not establish whether initial or periodic laboratory testing is required or what it would cost. It also does not specify clinician schedules or guaranteed message-response times. The app is advertised as a place to follow progress and adjust the plan, but that description does not establish a particular visit frequency. A useful included-costs checklist should distinguish named benefits from services whose availability or price remains unstated.

Insurance should be budgeted separately from the advertised package. He & She MD says it does not accept insurance, issue superbills or communicate with insurance carriers. Patients may submit receipts themselves, but reimbursement is not guaranteed. A separate $25 promotion applies to the first prescribed treatment, requires consultation and is subject to eligibility; not every patient qualifies. It should not be assumed to reduce every plan, every renewal or an already discounted offer without confirmation.

Sources: [13] [6] [9]

From free assessment to a prescription-dependent charge

The entry process begins with a free online assessment advertised as taking about five minutes. Questions address goals and medical history, after which the site says a licensed, board-certified U.S. physician reviews the questionnaire. A separate process graphic places provider review at approximately 24 hours. These are different time estimates: five minutes describes completing the form, and approximately 24 hours describes review. Neither establishes a delivery deadline or guarantees that a prescription will be issued.

The clearest payment protection advertised at enrollment is that a patient is charged only if medication is prescribed; someone who is not a candidate pays nothing. The terms require users to be at least 18 and located in a state where the relevant service operates. An educational article discusses BMI of 30 or higher, or 27 or higher with certain weight-related conditions, while emphasizing individualized assessment. Those thresholds are not a promise of admission, a prescription or a particular formulation.

The identity of the responsible medical organization needs clarification. The FAQ names Wasef Health, PC, care of Michael Wasef, MD, with contact@wasef-health.com and an office address at 5260 78th Ave N, PO Box 1697, Pinellas Park, Florida. The terms, dated November 1, 2022, instead describe a technology platform connecting users with Beluga Health or similar affiliated entities. The site also presents Ozita Cooper, MD, as chief medical officer with dual board certification. These are site claims, not independently verified credentials or a resolved responsibility map.

Sources: [9] [8] [6] [5]

Free shipping does not settle pharmacy access or delivery timing

He & She MD advertises GLP-1 shipping to every U.S. state except Louisiana, with no deliveries to PO boxes and discreet packaging. It describes expedited shipping as free. Its process graphic labels the delivery stage “2–3 days” and promises emailed tracking when prescribed medication ships from a U.S.-licensed pharmacy. The starting point for that estimate is not defined. It should not be read as a guaranteed arrival interval beginning when the assessment is submitted.

The named fulfillment partners are Specialty Medical Drugstore LLC, doing business as GoGoMeds, and F&F Pharmacies Inc, doing business as Jungle Jim’s Pharmacy. The FAQ says Jungle Jim’s is licensed in 44 states but lists ten excluded states: California, Nevada, New Jersey, North Carolina, Texas, Massachusetts, Mississippi, New Hampshire, West Virginia and Delaware. It also says that pharmacy cannot dispense sterile compounds. The numerical inconsistency and product restriction remain unresolved; fulfillment partnerships do not identify which pharmacy compounds a particular prescription.

Before paying, ask which pharmacy handles the selected formulation and destination, how an annual purchase is dispensed, and what happens if fulfillment is unavailable. General shipping coverage does not prove clinical or pharmacy availability for each product. The provider’s educational material says shipments are usually cold-packed, not that every shipment has a guaranteed temperature history. FDA explicitly advises not using an injectable GLP-1 product that arrives warm or inadequately refrigerated and contacting the provider or dispensing pharmacy.

Sources: [6] [9] [10] [1]

A pause clause is not a current-plan refund policy

The older terms describe pausing a membership by turning off automatic payments through the secure account or emailing support@heandshemd.com. They call this going “On-demand.” They also say a membership may be canceled without notice after eight consecutive weeks in that status without a continuation visit. These clauses document an account mechanism, but the current plans advertise no membership fees. The sources do not establish how that older membership framework applies to today’s prepaid GLP-1 purchases.

The supplied terms excerpts do not establish a complete cancellation, return or refund policy for current plans. Missing intermediate material further limits what can be concluded. There is no documented basis here to promise a prorated refund for unused months, reimbursement after dispensing or a particular deadline for stopping renewal. Conversely, the incomplete record does not prove that refunds are categorically unavailable. The important distinction is between stopping a future charge and recovering money already collected.

For a three-, six- or twelve-month purchase, request written answers about automatic renewal, required cancellation notice, the effective cancellation date and treatment of unfilled future shipments. Ask separately what happens if a clinician changes or discontinues the plan. Our guide to cancellation and refunds explains why those are separate financial questions. A low monthly equivalent is harder to evaluate when the purchaser cannot establish the rules governing the larger prepaid balance.

Sources: [6] [8]

Put ongoing care responsibilities into the cost comparison

Unlimited messaging and advertised 24/7 support may be useful benefits, but they should not be confused with continuous clinical monitoring. The telemedicine consent explicitly says asynchronous services are not emergency services and personal data will not be monitored around the clock. The sources do not specify guaranteed response times. Before relying on the bundle, establish where routine questions go, who responds to clinical concerns, and whether any additional appointment or outside evaluation would create a separate expense.

Communication channels also have different limits. Although commercial material describes encrypted information, the terms explicitly warn that SMS and email are not encrypted and may be intercepted. That distinction matters when sending medical or payment-related questions. Ask which channel should hold sensitive clinical information and which channel can confirm billing changes. A general support email is a contact route, not evidence that every message receives clinician review or that a cancellation request has already taken effect.

NIDDK describes medication choice as a discussion of benefits, side effects, health conditions, other medicines and costs, with follow-up addressing tolerance and response. Those responsibilities extend beyond processing renewals. The reviewed sources do not establish provider-specific clinical outcomes, and clinical trial results would not validate this service’s compounded preparations or oral formulations. For this cost review, the strongest comparison is therefore between a confirmed product, a documented payment obligation and a clearly described follow-up service—not between headline prices alone.

Sources: [13] [6] [8] [2] [3] [4]

Questions & answers

Can I pay $99 for just one month of injectable semaglutide?

The documented $99 monthly equivalent is tied to an annual arrangement: $1,188 annually on the plans page and purchase of 12 months of supply on the injectable page. Stand-alone monthly prices are $199 on the plans page and $249 on the injectable page. The sources do not resolve which applies.

Sources: [6] [13]

Does the six-month introductory price continue at renewal?

Not necessarily. Homepage notes describe an initial $139 monthly equivalent followed by a $1,194 six-month renewal, and an initial $199 equivalent followed by a $1,734 six-month renewal. Their relationship to every plan card is not fully established. Obtain the actual renewal amount for the selected product before paying.

Sources: [9]

Will He & She MD bill my insurance?

No. The provider says it does not accept insurance, supply superbills or communicate with insurers. You may independently submit receipts, but reimbursement is not guaranteed. Its injectable semaglutide page advertises HSA/FSA acceptance; that is separate from insurance coverage and does not establish an individual account’s reimbursement decision.

Sources: [6] [13]

Does an annual purchase mean all medication ships immediately?

The consulted sources do not establish that. The injectable page refers to purchasing 12 months of supply, while the plans page specifies annual collection. Neither resolves shipment frequency, quantity per shipment or the dispensing schedule. Ask for those details and the policy governing any future unfilled shipments.

Sources: [13] [6]

Can Louisiana residents receive the advertised GLP-1 shipments?

The plans page excludes Louisiana from its advertised GLP-1 shipping coverage and prohibits PO-box deliveries. Other states still require product-specific confirmation because clinical availability and pharmacy restrictions are separate issues. The named Jungle Jim’s pharmacy has additional listed state limitations and cannot dispense sterile compounds, according to the site.

Sources: [6]

Can I pause and receive a refund for unused prepaid months?

That is not established. Older terms describe disabling automatic membership payments through an account or support email, but their application to current no-membership-fee GLP-1 plans is unclear. They do not establish a complete current refund policy. Request separate written confirmation of cancellation, future billing and any refund for an existing purchase.

Sources: [8] [6]

Our assessment

He & She MD documents a potentially straightforward bundle: prescribed medication, injection supplies, shipping and ongoing messaging, with monthly and prepaid alternatives and no charge advertised when medication is not prescribed. Its financial documentation is less straightforward. Conflicting nonannual prices, introductory renewal notes, mislabeled oral tables and incomplete current cancellation terms prevent a confident single-price summary. The sensible next step is a written, product-specific quote identifying the initial collection, renewal amount, dispensing schedule, responsible clinical entity, pharmacy and refund boundaries. Until those points align, the lowest monthly equivalent is an advertised entry point—not a complete account of the purchase.

Visit He & She MD’s official site ↗

This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

He & She MD Review: The Monthly Price Is Only Part of the Cost

At a glance

01Start with the amount collected, not the monthly equivalent

02The competing price tables cannot be reconciled from the pages alone

03Oral tablets have separate prices—and labeling problems

04What the advertised payment includes

05From free assessment to a prescription-dependent charge

06Free shipping does not settle pharmacy access or delivery timing

07A pause clause is not a current-plan refund policy

08Put ongoing care responsibilities into the cost comparison

Questions & answers

Our assessment

Sources & documentation

Continue reading

Start with the amount collected, not the monthly equivalent

The competing price tables cannot be reconciled from the pages alone

Oral tablets have separate prices—and labeling problems

What the advertised payment includes

From free assessment to a prescription-dependent charge

Free shipping does not settle pharmacy access or delivery timing

A pause clause is not a current-plan refund policy

Put ongoing care responsibilities into the cost comparison